"Q. Vas, it's just another clarification investor question actually on tislelizumab. The question was, the 15 registration trials that Susanne mentioned, I'm being asked which of those \u2013 which regions and which indications are you going to be able to file? So I guess the question is really reflecting if you need any additional data in a specific country such as the US or parts of Europe in any specific indications."